Search

Dual Inhibitors of Src and Abl Tyrosine Kinases

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1 Issue: 3 Year: 2004 Page: 203-214
Author(s): Diane H. Boschelli

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 1-7
Author(s): Moustapha Zoubir, Thomas Tursz, Cedric Menard, Laurence Zitvogel, Nathalie Chaput

Measurement of Sediment (MESED) and LC-MS-MS for Cellular Kinetics Studies of STI-571(Imatinib, Gleevec® , Glivec®) in Cells with Different Pgp- 170 Expression

Journal: Current Analytical Chemistry
Volume: 1 Issue: 2 Year: 2005 Page: 121-127
Author(s): Hans Prenen, Gunther Guetens, Allan T. van Oosterom, Gert De Boeck, Martin S. Highley, Ernst A. de Bruijn

The Use of Computational Methods in the Discovery and Design of Kinase Inhibitors

Journal: Current Pharmaceutical Design
Volume: 8 Issue: 1 Year: 2002 Page: 1527-1545
Author(s): John R. Woolfrey, G. Scott Weston

Mechanisms of Resistance to Imatinib in CML Patients: A Paradigm for the Advantages and Pitfalls of Molecularly Targeted Therapy

Journal: Current Cancer Drug Targets
Volume: 6 Issue: 8 Year: 2006 Page: 645-657
Author(s): E. Ritchie, G. Nichols

Targeting Drug Resistant Mutations Using Novel Binding Interactions – Lessons Learned from Abl-T315I and their Implications in Drug Design

Ebook: Frontiers in Drug Design and Discovery
Volume: 3 Year: 2007
Author(s): Glen Noronha,Jianguo Cao,Chun Chow,Elena Dneprovskaia,Linda Hwang,Dan Lohse,Chi Ching Mak,Andrew McPherson,Richard M. Fine,Xinshan Kang,Boris Klebansky,Moorthy S.S. Palanki,Ved P. Pathak,Joel Renick,Richard Soll,Binqi Zeng
Doi: 10.2174/978160805201110703010121

Type II Kinase Inhibitors: An Opportunity in Cancer for Rational Design

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 731-747
Author(s): Javier Blanc, Raphael Geney, Christel Menet

Receptor Tyrosine Kinases: The Main Targets for New Anticancer Therapy

Journal: Current Drug Targets
Volume: 4 Issue: 2 Year: 2003 Page: 113-121
Author(s): Joachim Drevs, Michael Medinger, Carmen Schmidt-Gersbach, Renate Weber, Clemens Unger

Signal Transduction Therapy for Cancer - Whither Now?

Journal: Current Signal Transduction Therapy
Volume: 1 Issue: 1 Year: 2006 Page: 1-12
Author(s): Shoshana Klein, Alexander Levitzki

Chemical Genomic and Proteomic Methods for Determining Kinase Inhibitor Selectivity

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 10 Issue: 8 Year: 2007 Page: 652-666
Author(s): Ratika Krishnamurty, Dustin J. Maly